2023 Annual Conference
Chicago, IL
September 18th - 20th, 2023
IHFDA 7th Annual Conference
This is a Hybrid (In-person & Virtual) event
IHFDA is pleased to announce the 2023 annual conference this year in the Chicago area. The dates are September 18-20, 2023 at the Chicago Westin O’Hare in Rosemont, Illinois.
As in the past, the agenda will be packed full of the most up-to-date information on the diversion of medications in healthcare facilities. Look for a full agenda soon along with exhibitor opportunities.
IHFDA will also be offering the Fundamental Drug Diversion Course this year after the large attendance and positive feedback in 2022. In addition, the course is being improved with updated and additional training content within the diversion space. More information is available below.
The conference is available as in-person or hybrid, the diversion course is virtual with a live (in-person & virtual) Q&A with the panel.
Conference Attendee $400
Conference RegistrationSpeaker / Corporate Member
Other RegistrationExhibitor Information
Exhibitor RegistrationCall for Proposals & Presentations
IHFDA’s conference planning committee seeks abstracts for podium, poster, and panel presentations that address topics on diversion, risk management, quality practice, and guidelines/processes used to increase the knowledge and skills of all professionals and promote the development of our profession. Proposals on any major topic related to healthcare facility diversion are welcome for consideration.
Fundamental Drug Diversion Certificate
Fundamental Drug Diversion Certificate Agenda
"Drug Diversion: Personal Impacts, Patient Harm and Unexpected Outcomes” (1 hour)
“Overview of Institutional Drug Diversion” (1 hour)
“Drug Diversion Interviews in Healthcare: Gateway to the Truth” (1 hour)
“The Public Health Perspective: Injectable Drug Diversion and Bloodborne Pathogens Transmission” (1 hour)
“Developing a Comprehensive Drug Diversion Monitoring Program” (3 hours)
“The Intersection of Peer Support and Substance Use Disorder in Nurses” (1 hour)
“Overview of Institutional Drug Diversion” (1 hour)
“Drug Diversion Interviews in Healthcare: Gateway to the Truth” (1 hour)
“The Public Health Perspective: Injectable Drug Diversion and Bloodborne Pathogens Transmission” (1 hour)
“Developing a Comprehensive Drug Diversion Monitoring Program” (3 hours)
“The Intersection of Peer Support and Substance Use Disorder in Nurses” (1 hour)
About Fundamental Drug Diversion Certificate
The IHFDA Executive Board is proud to once again offer the fundamental course on drug diversion inside healthcare facilities. This groundbreaking 8-hour compilation of some of the most experienced and trusted experts in this field should prove extremely helpful whether you are just starting to seriously look at drug diversion inside your institution or you have been doing it for several years.
IHFDA has updated and added new training content from last year, and we feel that this course will address the main concerns of everyone who is tasked with these crucial investigations, with the ability to ask questions of the actual presenters. The presenters are either currently working on drug diversion inside a healthcare facility, or have spent many years in the field.
This is something many of you in the field have been asking for years to be available for your new people into this area of investigation and those who desire a refresher course while also seeing the most recent methods and means of today’s investigators.
The first offering of this course will provide continuing education credits. The cost for the virtual course is $200.
IHFDA has updated and added new training content from last year, and we feel that this course will address the main concerns of everyone who is tasked with these crucial investigations, with the ability to ask questions of the actual presenters. The presenters are either currently working on drug diversion inside a healthcare facility, or have spent many years in the field.
This is something many of you in the field have been asking for years to be available for your new people into this area of investigation and those who desire a refresher course while also seeing the most recent methods and means of today’s investigators.
The first offering of this course will provide continuing education credits. The cost for the virtual course is $200.
Conference Agenda
Download Agenda
**Agenda is subject to change**
Day 1
Day 2
Day 3
Poster Presentations
9/18/2023 - Monday - CENTRAL TIME ZONE
8:00 A.M. - 9:00 A.M.
Fundamental Drug Diversion Certificate Panel Discussion & Final Remarks
**Attendance is restricted to certificate participants only**
9:15 A.M. - 9:30 A.M.
Welcome and Opening Remarks – Start of Annual Conference
9:30 A.M. – 10:30 A.M.
Catch Me (if you can): The Impaired Provider
Rodrigo Garcia, MBA, MSN, APN-BC, CRNA, Parkdale
Claudia Garcia, MBA, BSN, CADAC II, LAC, Parkdale
Claudia Garcia, MBA, BSN, CADAC II, LAC, Parkdale
10:30 A.M. – 11:30 A.M.
Details Matter: ASHP Controlled Substances Diversion Gap – Assessment Tool to Mitigate Risk
Mary Nelson, MSN, RN, HonorHealth
JoAnne Myhre, CPhT, FMSHP, BA, Alina Health
JoAnne Myhre, CPhT, FMSHP, BA, Alina Health
11:30 A.M. – 12:15 P.M.
Lunch & Time with Exhibitors
12:15 P.M. – 1:15 P.M.
Diversion: The Emotional Connection Interview
Kevin Vanover, Protective Services Investigator, TriHealth
Additional speaker – TBD
Additional speaker – TBD
1:15 P.M. – 2:15 P.M.
Implementation of a Targeted Waste Testing Program in Two Large Academic Health Systems
Amisha Arya, PharmD, BCSCP, CJCP, NYU Langone Health
Nhan Cho, PharmD, NewYork-Presbyterian
Jorie Frasiolas, PharmD, BCPS, NewYork-Presbyterian
Nhan Cho, PharmD, NewYork-Presbyterian
Jorie Frasiolas, PharmD, BCPS, NewYork-Presbyterian
2:15 P.M. – 3:00 P.M.
Posters & Time with Exhibitors
3:00 P.M. – 4:00 P.M.
Partnering for Patient Safety – Exploring the Role of Infection Prevention in a Drug Diversion Investigation
Amanda Hays, PharmD, MHA, BCPS, CPHQ, DPLA, FASHP, Becton, Dickinson Company
Rachael Snyders, MPH, BSN, RN, CIC, FAPIC, Becton, Dickinson Company
Rachael Snyders, MPH, BSN, RN, CIC, FAPIC, Becton, Dickinson Company
4:00 P.M. – 5:15 P.M
Would YOU Raise YOUR Hand?
Moderator: Rodrigo Garcia
Terri Vidals, BS Pharm, Rxpert Solutions
Mary Nelson, MSN, RN, CPPS, HonorHealth
Alecia Pittman, BSN, RN, BA, Cooper Health
Kristin Waite-Labott, BSN, RN, BA, Freedom Institute
Terri Vidals, BS Pharm, Rxpert Solutions
Mary Nelson, MSN, RN, CPPS, HonorHealth
Alecia Pittman, BSN, RN, BA, Cooper Health
Kristin Waite-Labott, BSN, RN, BA, Freedom Institute
5:15 P.M. – 6:30 P.M.
Networking / Social Hour & Time with Exhibitors
Drinks and Light Snacks - In The Exhibitor Hall
9/19/2023 - Tuesday - CENTRAL TIME ZONE
8:15 A.M. – 9:00 A.M.
IHFDA Membership Meeting and Committee Updates
9:00 A.M. – 10:00 A.M.
DEA Inspections: What’s Compliance Got to Do With It?
Joseph Nguyen, PharmD, MBA, CHC, CPPS, UT Southwestern Medical Center
Elizabeth Daniel, PharmD, BCPS, BCCCP, UT Southwestern Medical Center
Elizabeth Daniel, PharmD, BCPS, BCCCP, UT Southwestern Medical Center
10:00 A.M. – 11:15 A.M.
Diversion Happens in Happy Places Too: Pediatric Perspectives in Diversion Programs
Karen Lettre, MSN, RN, Texas Children’s Hospital
Lacey Rodgers, PharmD, MHA, BCSCP, St. Louis Children’s Hospital
Heidi McNeely, PhD, RN, PCNS-BC, Children’s Hospital Colorado
Lacey Rodgers, PharmD, MHA, BCSCP, St. Louis Children’s Hospital
Heidi McNeely, PhD, RN, PCNS-BC, Children’s Hospital Colorado
11:15 A.M. – 12:00 P.M.
Lunch & Time with Exhibitors
12:00 P.M. – 1:15 P.M.
Drug Diversion Detection and Prevention in the Hospital Pharmacy Department
Samantha Bastow, PharmD, MBA, Becton Dickinson (Moderator)
Anthony Scott, PharmD, MBA, Emory University Hospital
Nathan Mills, PharmD, CPPS, Appalachian Regional Health
Alex Raymond, PharmD, MS, CHC, Ochsner Health
Anthony Scott, PharmD, MBA, Emory University Hospital
Nathan Mills, PharmD, CPPS, Appalachian Regional Health
Alex Raymond, PharmD, MS, CHC, Ochsner Health
1:15 P.M. – 2:15 P.M.
Across State Lines: Effectively Leading a Multi-State Medication Diversion Program
Alissa Voils, PharmD, BSHA, Mayo Clinic
OR (select One)
When You Get the Call: Launching a suspected diversion investigation
Sharron Coffie, MSN, RN, CNS, UT Southwestern Medical Center
2:15 P.M. – 3:00 P.M.
Poster Presenter Session & Break
3:00 P.M. – 4:00 P.M.
Assessing and Treating Addiction: Shedding Blinders and Utilizing Practical Approaches
John Anish, MD, ABPN, ABPM, Northwestern University Feinberg School of Medicine
4:00 P.M. – 5:00 P.M.
Beyond the Investigation – Developing Defined Processes for Multidisciplinary Coordination Pre- and Post-Employee Interview
Cory Luper, BA, Atrium Health Wake Forest Baptist
Leah Mitchell, PharmD, MBA, Atrium Health Wake Forest Baptist
Leah Mitchell, PharmD, MBA, Atrium Health Wake Forest Baptist
9/20/2023 - Wednesday - CENTRAL TIME ZONE
8:00 A.M. – 8:50 A.M.
Vendor Breakfast
9:00 A.M. – 10:00 A.M.
Non-Controlled Drug Discrepancy Reports (if you’re not looking, you don’t know what you’re missing!)
Stephen Webster, PharmD, MSBA, University of Rochester Medical Center
10:00 A.M. – 11:00 A.M.
The ROUST Journey: Implementing an Opioid Stewardship Program in a Health System
Michael Dejos, PharmD, MBA, BCPS, CHOP, LSSBB, DPLA, Methodist Le Bonheur Healthcare
11:00 A.M. – 12:15 P.M.
Closing Session - TBD
12:15 P.M. – 12:30 P.M.
Closing Remarks and Lunch to Go
Addressing Unresolved Controlled Substance Discrepancies and Increasing the Number of Controlled Substance Dispenses from Automated Dispensing Cabinets
Andreece Gandy, PharmD, MBA, Methodist Le Bonheur Hospital - North
AI Bias Considerations in Drug Diversion Detection and Prevention Programs
Samantha Bastow,PharmD, MBA
Scott Smith, PhD, Becton Dickinson
Scott Smith, PhD, Becton Dickinson
Measuring Program Success through Key Performance Indicators
Danielle Neal, PharmD, MBA, BCPS
Leah Mitchell, PharmD, MBA, Atrium Health Wake Forest Baptist
Leah Mitchell, PharmD, MBA, Atrium Health Wake Forest Baptist
Opioid Safety Awareness 101: Getting Back to the Basics!
Summera Zaheer, MHA, CLSSGB
Sharron Coffie, MSN, RN, CNS, UT Southwestern Medical Center
Sharron Coffie, MSN, RN, CNS, UT Southwestern Medical Center
Safeguarding Medication Risk by Reducing Overrides
Nic Jenkins, BSHA, AAS, CPhT
Heidi McNeely, PhD, RN, PCNS-BC, Children’s Hospital Colorado
Heidi McNeely, PhD, RN, PCNS-BC, Children’s Hospital Colorado
Surveillance data does not tell you this...
Colleen Connelly, MPH, RN, Visante
Timeline of Development for a System Drug Diversion Program: Past, Present, and Future
Bailey Eason, PharmD, MS, BCPS
Jennifer Wooten, BS, PharmD, BCPS
Kristen March, Northwestern Medicine
Jennifer Wooten, BS, PharmD, BCPS
Kristen March, Northwestern Medicine
Travel Nurses at a Travel Destination
Amina Luzic, PharmD, RPh
Joel Seeram, PharmD, RPh, Martha’s Vineyard Hospital
Joel Seeram, PharmD, RPh, Martha’s Vineyard Hospital
Which Drug Diversion Monitoring Approach Reigns Supreme? A Retrospective Study to Compare the Outcomes of Report-based and Case-based Diversion Monitoring
Russell Dorsey, CPhT-Adv, CCSM
Adam Beeler, PharmD, MS, Protenus
Adam Beeler, PharmD, MS, Protenus
Conference Exhibitors (A-Z)
